Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Service d'aide à la décision clinique
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Gynécologie Obstétrique & Fertilité
Volume 40, n° 12
pages 784-786 (décembre 2012)
Doi : 10.1016/j.gyobfe.2012.09.005
Received : 20 April 2012 ;  accepted : 18 July 2012
Exposition anténatale au diéthylstilbestrol et cancer du sein
Prenatal diethylstilbestrol exposure and breast cancer
 

S. Frigo , C. Malina, C. Mathelin
Unité de sénologie, pôle de gynécologie-obstétrique, CHRU de Strasbourg, avenue Molière, 67200 Strasbourg cedex, France 

Auteur correspondant.
Résumé

Le diéthylstilbestrol (DES) est un estrogène de synthèse prescrit pour la prévention des fausses couches jusqu’en 1977. Son rôle dans le développement d’adénocarcinomes vaginaux et de dysplasies cervicales est connu et le dépistage codifié. Des études de cohortes récentes montrent que l’exposition in utero au DES entraîne un sur-risque de cancer du sein, notamment après 40ans. Cet article relate l’observation d’un cancer du sein d’une exceptionnelle gravité chez une patiente exposée in utero au DES. Il détaille les risques de cancer du sein pour les « filles DES » tout en proposant des modalités de dépistage.

The full text of this article is available in PDF format.
Abstract

Diethylstilbestrol (DES) is a synthetic estrogen prescribed to prevent miscarriages until 1977. Its role in the development of vaginal adenocarcinoma and cervical dysplasia is known and screening codified. Recent cohort studies show that exposure to DES in utero increases breast cancer risk especially after 40years. This article reports the observation of a breast cancer of exceptional gravity in a patient exposed to DES in utero . It details the risk of breast cancer for “DES daughters” and support possible screening modalities.

The full text of this article is available in PDF format.

Mots clés : Cancer du sein, Dépistage, Diéthylstilbestrol, Exposition in utero

Keywords : Breast cancer, Diethylstilbestrol, In utero exposure, Screening




© 2012  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline